Literature DB >> 221783

Reduction of plasma triglyceride concentration by acute stress in man.

A Chait, J D Brunzell, D G Johnson, J W Benson, P Werner, J P Palmer, J J Albers, J W Ensinck, E L Bierman.   

Abstract

Three different forms of stress all resulted in acute reduction of plasma triglyceride concentrations. Pyrogen reactions in two hypertriglyceridemic men resulted in the lowering of very-low-density lipoprotein (VLDL) triglyceride levels by 93% and 73% due to decreased secretion of this lipoprotein into plasma. More modest reductions in plasma triglycerides were observed after 2-deoxyglucose-induced intracellular glucopenia and insulin-induced hypoglycemia. With hypoglycemia, the lowering of plasma triglyceride concentration correlated significantly with the stimulation of urinary epinephrine output (r = 0.86) but with neither the urinary norepinephrine response nor with the increase in plasma immunoreactive glucagon levels. To further test whether these changes in plasma triglyceride levels were mediated via the sympathetic nervous system, hypoglycemia was evoked by insulin in subjects with traumatic spinal cord transactions. Two such subjects, who demonstrated sympathetic stimulation in response to hypoglycemia, had evidence of reduced VLDL secretion into plasma, while in two who had no evidence of an adrenergic response. VLDL secretion was not inhibited. Thus, acute lowering of plasma triglyceride concentrations by certain forms of stress appears to be mediated via the sympathetic nervous system.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221783     DOI: 10.1016/0026-0495(79)90197-5

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  12 in total

1.  Acute hypoxia induces hypertriglyceridemia by decreasing plasma triglyceride clearance in mice.

Authors:  Jonathan C Jun; Mi-Kyung Shin; Qiaoling Yao; Shannon Bevans-Fonti; James Poole; Luciano F Drager; Vsevolod Y Polotsky
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.310

2.  Type A behavior and central serous chorioretinopathy.

Authors:  L A Yannuzzi
Journal:  Trans Am Ophthalmol Soc       Date:  1986

Review 3.  [Theory and practice of perioperative trauma-adapted parenteral feeding].

Authors:  M Georgieff
Journal:  Z Ernahrungswiss       Date:  1982-12

4.  Alpha-adrenergic suppression of very-low-density-lipoprotein triacylglycerol secretion by isolated rat hepatocytes.

Authors:  N P Brindle; J A Ontko
Journal:  Biochem J       Date:  1988-03-01       Impact factor: 3.857

5.  Metabolic effects of prazosin on skeletal muscle insulin resistance in glucocorticoid-treated male rats.

Authors:  Emily C Dunford; Erin R Mandel; Sepideh Mohajeri; Tara L Haas; Michael C Riddell
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-11-09       Impact factor: 3.619

6.  Conditions that result in the mobilization and influx of Ca2+ into rat hepatocytes induce the rapid loss of 3-hydroxy-3-methylglutaryl-CoA reductase activity that is not reversed by phosphatase treatment.

Authors:  V A Zammit; A M Caldwell
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

Review 7.  Assembly and secretion of hepatic very-low-density lipoprotein.

Authors:  G F Gibbons
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

8.  Thermoneutrality modifies the impact of hypoxia on lipid metabolism.

Authors:  Jonathan C Jun; Mi-Kyung Shin; Qiaoling Yao; Ronald Devera; Shannon Fonti-Bevans; Vsevolod Y Polotsky
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-18       Impact factor: 4.310

9.  [Advantage of xylitol compared to glucose as an energy source during early postoperative parenteral feeding].

Authors:  M Georgieff; R H Ackermann; K H Bässler; H Lutz
Journal:  Z Ernahrungswiss       Date:  1982-03

10.  [Enzymatic changes and protein metabolism in the early and late postoperative phase during intravenous feeding].

Authors:  M Georgieff; H Lutz
Journal:  Z Ernahrungswiss       Date:  1981-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.